<!doctype html><html lang=en-us><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><meta property="og:site_name" content="JazzVibe"><meta property="og:type" content="article"><meta name=robots content="index,follow,noarchive"><meta property="og:image" content="//img/home-bg-jeep.jpg"><meta property="twitter:image" content="//img/home-bg-jeep.jpg"><meta name=title content="1 in 3 Parents Interested in Weight Loss Drugs for Their Kids"><meta property="og:title" content="1 in 3 Parents Interested in Weight Loss Drugs for Their Kids"><meta property="twitter:title" content="1 in 3 Parents Interested in Weight Loss Drugs for Their Kids"><meta name=description content="With robust sample sizes, Morning Consults public opinion data can be analyzed by specific demographics, such as gender, generation, political party, income, race and more. Please contact[emailprotected]to purchase this data."><meta property="og:description" content="With robust sample sizes, Morning Consults public opinion data can be analyzed by specific demographics, such as gender, generation, political party, income, race and more. Please contact[emailprotected]to purchase this data."><meta property="twitter:description" content="With robust sample sizes, Morning Consults public opinion data can be analyzed by specific demographics, such as gender, generation, political party, income, race and more. Please contact[emailprotected]to purchase this data."><meta property="twitter:card" content="summary"><meta name=keyword content><link rel="shortcut icon" href=./img/favicon.ico><title>1 in 3 Parents Interested in Weight Loss Drugs for Their Kids |</title><link rel=canonical href=./consumer-interest-weight-loss-drugs-for-children.html><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cleanwhite/css/bootstrap.min.css><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cleanwhite/css/hugo-theme-cleanwhite.min.css><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cleanwhite/css/zanshang.css><link href=https://cdn.jsdelivr.net/gh/FortAwesome/Font-Awesome@5.15.1/css/all.css rel=stylesheet type=text/css><script src=https://assets.cdnweb.info/hugo/cleanwhite/js/jquery.min.js></script>
<script src=https://assets.cdnweb.info/hugo/cleanwhite/js/bootstrap.min.js></script>
<script src=https://assets.cdnweb.info/hugo/cleanwhite/js/hux-blog.min.js></script></head><nav class="navbar navbar-default navbar-custom navbar-fixed-top"><div class=container-fluid><div class="navbar-header page-scroll"><button type=button class=navbar-toggle>
<span class=sr-only>Toggle navigation</span>
<span class=icon-bar></span>
<span class=icon-bar></span>
<span class=icon-bar></span></button>
<a class=navbar-brand href=./>JazzVibe</a></div><div id=huxblog_navbar><div class=navbar-collapse><ul class="nav navbar-nav navbar-right"><li><a href=./categories/celeb>celeb</a></li><li><a href=./sitemap.xml>Sitemap</a></li><li><a href=./index.xml>RSS</a></li></ul></div></div></div></nav><script>var $body=document.body,$toggle=document.querySelector(".navbar-toggle"),$navbar=document.querySelector("#huxblog_navbar"),$collapse=document.querySelector(".navbar-collapse");$toggle.addEventListener("click",handleMagic);function handleMagic(){$navbar.className.indexOf("in")>0?($navbar.className=" ",setTimeout(function(){$navbar.className.indexOf("in")<0&&($collapse.style.height="0px")},400)):($collapse.style.height="auto",$navbar.className+=" in")}</script><style type=text/css>header.intro-header{background-image:url(/img/home-bg-jeep.jpg)}</style><header class=intro-header><div class=container><div class=row><div class="col-lg-8 col-lg-offset-2 col-md-10 col-md-offset-1"><div class=post-heading><div class=tags></div><h1>1 in 3 Parents Interested in Weight Loss Drugs for Their Kids</h1><h2 class=subheading></h2><span class=meta>Posted by
Kelle Repass
on
Friday, August 23, 2024</span></div></div></div></div></header><article><div class=container><div class=row><div class="col-lg-8 col-lg-offset-2
col-md-10 col-md-offset-1
post-container"><img src=https://cdn.statically.io/img/pro-assets.morningconsult.com/wp-uploads/2023/11/ozempic-for-chidlren-231204.jpg style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class="mb-m last:mb-0 text-body-large"><strong><i>With robust sample sizes, Morning Consult’s public opinion data can be analyzed by specific demographics, such as gender, generation, political party, income, race and more. Please contact&nbsp;</i><i><a class="items-center outline-2 outline-offset-2 focus-visible:outline-brand cursor-pointer hover:underline underline text-primary hover:text-primary-900 visited:text-primary-900" tabindex=0 href=#><span class=__cf_email__ data-cfemail=58282a371835372a3631363f3b37362b2d342c763b3735>[email&nbsp;protected]</span></a></i><i>&nbsp;to purchase this data.</i></strong></p><p class="mb-m last:mb-0 text-body-large">GLP-1 weight loss drugs like Ozempic are expected to be a boon for pharmaceutical companies in the coming years, as obesity affects roughly 2 in 5 Americans, a <a class="items-center outline-2 outline-offset-2 focus-visible:outline-brand cursor-pointer hover:underline underline text-primary hover:text-primary-900 visited:text-primary-900" tabindex=0 href=#>majority of adults</a> say they feel the need to lose weight and <a class="items-center outline-2 outline-offset-2 focus-visible:outline-brand cursor-pointer hover:underline underline text-primary hover:text-primary-900 visited:text-primary-900" tabindex=0 href=#>almost 3 in 10 Americans</a> are interested in taking these drugs. Now, drugmakers are even considering adding a new consumer base: children.&nbsp;</p><p class="mb-m last:mb-0 text-body-large">GLP-1 makers Novo Nordisk and Eli Lilly are <a class="items-center outline-2 outline-offset-2 focus-visible:outline-brand cursor-pointer hover:underline underline text-primary hover:text-primary-900 visited:text-primary-900" tabindex=0 href=#>testing the safety and efficacy of these drugs</a> for children as young as 6 years old. While obesity has a significant impact on the adult population, more than 14 million U.S. children and adolescents are also struggling with it. The issue even spurred the American Academy of Pediatrics in January to <a class="items-center outline-2 outline-offset-2 focus-visible:outline-brand cursor-pointer hover:underline underline text-primary hover:text-primary-900 visited:text-primary-900" tabindex=0 href=#>recommend the use</a> of weight loss drugs for children ages 12 and older to fight obesity.&nbsp;</p><p class="mb-m last:mb-0 text-body-large">The use of weight loss drugs among children is a divisive issue, but amid America’s obesity crisis, many parents are considering the treatment for their own kids. New Morning Consult data shows 1 in 3 parents of children under 18 said they are “definitely” or “probably” interested in having their children use GLP-1 prescription drugs if they were available.</p><h2 class="font-semibold text-headline2 leading-headline2 mb-m"><strong>GLP-1 interest is high among parents who have children with weight-related issues</strong></h2><p class="mb-m last:mb-0 text-body-large">The share of interested parents was slightly higher among those who have children ages 6 to 11. The highest interest among parents was those with children who have weight-related issues, at 65%. Childhood obesity can lead to several <a class="items-center outline-2 outline-offset-2 focus-visible:outline-brand cursor-pointer hover:underline underline text-primary hover:text-primary-900 visited:text-primary-900" tabindex=0 href=#>physical health complications</a> like Type 2 diabetes, high blood pressure, joint pain and breathing problems, in addition to social and emotional issues linked to teasing or bullying.</p><p class="mb-m last:mb-0 text-body-large">While parental intrigue in these drugs is high, almost half of parents (46%) are “probably not” or “definitely not” interested in having their children take GLP-1 drugs. One in 5 parents said they don’t know or have no opinion on the drugs, suggesting some could be swayed if clinical tests among children show positive results.</p><h2 class="font-semibold text-headline2 leading-headline2 mb-m"><strong>Parents are more likely than the public to support GLP-1 drugs to fight childhood obesity</strong></h2><p class="mb-m last:mb-0 text-body-large">Morning Consult data also shows that parents are more likely than the general public to support the use of GLP-1 prescription drugs to help address childhood obesity.</p><p class="mb-m last:mb-0 text-body-large">Among all U.S. adults, 28% said they support the use of prescription GLP-1 weight loss drugs to fight childhood obesity. The shares of supporters were higher among parents of children ages 6-11 (44%), ages 12-17 (38%) and children with weight-related issues (58%). The general public was more likely to oppose than support the use of these drugs among kids, though a high share of adults (32%) said they didn’t know or had no opinion on the matter.&nbsp;</p><p class="mb-m last:mb-0 text-body-large">Part of this uncertainty could be due to a lack of awareness: Just 29% of adults have seen, read or heard at least something about drug companies’ interest in making the drugs available to children as young as 6, while the various parent groups were more likely to have heard this news. The public is still waiting to hear the results of GLP-1 clinical tests among children, so many Americans are probably holding out on forming an opinion until they have scientific data to do so.</p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmiooqR7rrvRp6Cnn5Oku7TBy61lnKedZK6vrcuyqqKrX5i8r7%2FUppyrZZmjwaa%2BxKyrZq%2BVnrSpwIylpqyrXZm%2FtrPSZp2oql2Ytaq4w6ucpw%3D%3D</p><hr><ul class=pager><li class=previous><a href=./1479564-100-creative-intriguing-private-story-names-snapchat.html data-toggle=tooltip data-placement=top title="100+ creative and intriguing private story names for Snapchat">&larr;
Previous Post</a></li><li class=next><a href=./1582601-24-hours-bet9ja-breaks-silence-nigerian-man-wins-n110-million-days.html data-toggle=tooltip data-placement=top title="&amp;quot;Within 24 Hours&amp;quot;: Bet9ja Breaks Silence After Nigerian Man Wins N110 Million in Less Than Two Days">Next
Post &rarr;</a></li></ul></div><div class="col-lg-2 col-lg-offset-0
visible-lg-block
sidebar-container
catalog-container"><div class=side-catalog><hr class="hidden-sm hidden-xs"><h5><a class=catalog-toggle href=#>CATALOG</a></h5><ul class=catalog-body></ul></div></div><div class="col-lg-8 col-lg-offset-2
col-md-10 col-md-offset-1
sidebar-container"><section><hr class="hidden-sm hidden-xs"><h5><a href=./tags/>FEATURED TAGS</a></h5><div class=tags></div></section></div></div></div></article><footer><div class=container><div class=row><div class="col-lg-8 col-lg-offset-2 col-md-10 col-md-offset-1"><ul class="list-inline text-center"></ul><p class="copyright text-muted">Copyright &copy; JazzVibe 2024<br><a href=https://themes.gohugo.io/hugo-theme-cleanwhite>CleanWhite Hugo Theme</a> |
<iframe style=margin-left:2px;margin-bottom:-5px frameborder=0 scrolling=0 width=100px height=20px src="https://ghbtns.com/github-btn.html?user=zhaohuabing&repo=hugo-theme-cleanwhite&type=star&count=true"></iframe></p></div></div></div></footer><script>function loadAsync(i,t){var n=document,s="script",e=n.createElement(s),o=n.getElementsByTagName(s)[0];e.src=i,t&&e.addEventListener("load",function(e){t(null,e)},!1),o.parentNode.insertBefore(e,o)}</script><script>$("#tag_cloud").length!==0&&loadAsync("/js/jquery.tagcloud.js",function(){$.fn.tagcloud.defaults={color:{start:"#bbbbee",end:"#0085a1"}},$("#tag_cloud a").tagcloud()})</script><script>loadAsync("https://cdn.jsdelivr.net/npm/fastclick@1.0.6/lib/fastclick.min.js",function(){var e=document.querySelector("nav");e&&FastClick.attach(e)})</script><script type=text/javascript>function generateCatalog(e){_containerSelector="div.post-container";var t,n,s,o,i,r=$(_containerSelector),a=r.find("h1,h2,h3,h4,h5,h6");return $(e).html(''),a.each(function(){n=$(this).prop("tagName").toLowerCase(),i="#"+$(this).prop("id"),s=$(this).text(),t=$('<a href="'+i+'" rel="nofollow">'+s+"</a>"),o=$('<li class="'+n+'_nav"></li>').append(t),$(e).append(o)}),!0}generateCatalog(".catalog-body"),$(".catalog-toggle").click(function(e){e.preventDefault(),$(".side-catalog").toggleClass("fold")}),loadAsync("https://assets.cdnweb.info/hugo/cleanwhite/js/jquery.nav.js",function(){$(".catalog-body").onePageNav({currentClass:"active",changeHash:!1,easing:"swing",filter:"",scrollSpeed:700,scrollOffset:0,scrollThreshold:.2,begin:null,end:null,scrollChange:null,padding:80})})</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://iklan.listspress.com/floating.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://iklan.listspress.com/tracking_server_3.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>